Scientist Solutions: International Life Science Community By Scientists For Scientists
Home » Societies » The Biotech Research Society of India Forum

The Biotech Research Society of India Forum

Thanks to our sponsors who make this site possible
Welcome Members and guests. Our Forum is brought to you through our partnership with Scientist Solu- which manages these pages to promote the free exchange of useful scientific information. We
encourage you to dive in and join the conversation!

How do I use this forum?
Registered members can create new topics and reply to topics from other users. To learn more about s-
uccessful posting in the forums Click Here. Subscribing to Society Sub-forums will keep you informed
and involved.
Disclaimer - The The Biotech Research Society of India Society supports the free exchange of scientific information, but is not responsible or liable for comments made in public forums such as this one. Topics and posts deemed unsuitable will be moderated and removed.

The Biotech Research Society of India Subforums

RSS Feed
Sub-forumsTopics  Replies  ViewsLast Post

Strategies to Identify Drug Targets/Biomarkers

22 23 36182

Urgent Dilution problem! Please hel ...

by Saluferkimo
May 21, 2015, 15:24 PM

Target Validation Techniques

Target Validation Techniques
9 9 24692


by skarthikumar
Nov 09, 2012, 11:02 AM


Extent and rate of absorption, distribution, metabolism and excretion ( ADME)
18 46 53481


by Debbie Reed Bietz
Jun 25, 2012, 11:25 AM

Bioprocessing/Scale Up and Isolation

Fermentation, cell culture, expression, and recovery
22 27 37696

isolating dna from spotted on filte ...

by Pippuri
May 04, 2015, 16:26 PM

Good Manufacturing/Validation Practice (GMP/GVP)

Control and management
24 51 52069

Performance Qualification (PQ) of L ...

by Eibhor
Aug 17, 2015, 21:01 PM


Pharmacology equipment
18 49 47456

How to choose your system Fiber opt ...

by Idealphotonics
Oct 05, 2015, 6:41 AM

Assay Development & Protocols

Also, remember to visit the protocols tab on the homepage toolbar
48 46 60052

Xanthine Oxidase Inhibitory Assay

by Paye
Feb 27, 2012, 20:34 PM

Society Overview

The aims & objectives of the Biotech Research Society [BRSI] are:
  • To promote the R&D in biotechnology in India
  • To bring interaction between the academic institutes and the biotech industries, interact with the industries and help them in resolving their problems, as well make them aware with the latest developments in the biotech sector
  • To provide and arrange the training in biotechnology, dissemination of biotech knowledge through the organization of the lectures, seminars and symposia on the scientific programmes and societal missions.

Contact Society Forum Organizer
Society Organizer: Ashok Pandey

Click here to
Become a member & join our
community (It's easy & free)
Already a member? Please log in
User Name  
Forget Password?
News Feeds from
BioTech News
Biotech news continually updated from thousands of sources around the net.

Chicago Equity Partners LLC lessened its stake in shares of Agenus Inc by 38.6% in the 1st quarter, Holdings Channel reports. The institutional investor owned 214,675 shares of the biotechnology company's stock after selling 134,950 shares during the quarter.

Brokerages expect Inogen to post earnings per share of $0.44 for the current fiscal quarter, according to Zacks . Four analysts have issued estimates for Inogen's earnings, with the highest EPS estimate coming in at $0.47 and the lowest estimate coming in at $0.40.

According to a Centers for Disease Control and Prevention report released on Thursday, May 17... Last year saw the lowest number of U.S. births in 30 years, with birth rates declining not only for women in their teens and 20s but also women in their 30s. Last year saw the lowest number of U.S. births in 30 years, with birth rates declining not only for women in their teens and 20s but also women in their 30s.

ClariVest Asset Management LLC lowered its stake in Spectrum Pharmaceuticals by 10.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 219,918 shares of the biotechnology company's stock after selling 24,631 shares during the period.

We recently got the first glimpse of what that label might look like, when the U.S. Department of Agriculture released its proposed guidelines . This is the product of a decades-long fight between anti-GMO campaigners and Big Agriculture companies, which left neither side completely satisfied, as NPR has reported .

Banque Pictet & Cie SA acquired a new stake in Teva Pharmaceutical Industries during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 94,790 shares of the company's stock, valued at approximately $1,608,000.

According to Zacks, "Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products.

An Asheville, North Carolina company on Friday night became the latest to recall supplements containing kratom, a Southeast Asian herb, after government tests showed the presence of salmonella. Pious Lion of Asheville voluntarily recalled two kratom powder products after samples collected by the state from a retailer tested positive for the potentially fatal bacteria, according to a news release from the N.C. Department of Agriculture and Consumer Services on Friday night.

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we're talking about! Here is some more information if you're curious .

Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues, the latest drugmaker to abandon developing treatments for the memory-robbing disease. Some trial participants showed serious elevations of liver enzymes and the company concluded that the benefit-risk ratio offered by the drug, atabecestat, no longer supported its development, said Janssen, a unit of Johnson and Johnson.

Bertila Boyd-Bostic was looking forward to starting a family once she and her husband, Antoine Bostic, both graduates of Mercer University School of Law in Georgia, had built their own law firm, Bostic & Boyd, in Columbia, South Carolina. But in 2016, she was diagnosed with mesothelioma and, on Oct. 29, died at age 30. Her husband is now part of a trial against Johnson & Johnson, claiming Boyd-Bostic's lifetime use of its baby powder caused her to get one of the deadliest forms of cancer.

May 18, 2018-- AstraZeneca today announced that the US Food and Drug Administration has approved LOKELMA TM , formerly ZS-9, for the treatment of hyperkalemia in adults. 3 Hyperkalemia is a serious condition characterized by high levels of potassium in the blood .

U.S. and European regulators said they were assessing evidence that GlaxoSmithKline's HIV drug dolutegravir might be linked to serious birth defects, casting a shadow over a medicine that has been a key profit driver in recent years. The GlaxoSmithKline logo is seen on top of GSK Asia House in Singapore, March 21, 2018.

Two new studies published in the New England Journal of Medicine suggests newly tested drugs could cut painful monthly migraines by half. The Food and Drug Administration's action clears the monthly shot Aimovig for sale.

Trinity Biotech and New England Nuclear are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Trinity Biotech has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500.

According to the Atlanta-based Centers for Disease Control and Prevention , the common cold infects millions of Americans every year and is the main reason for children missing school and adults missing work. The average adult gets two to three colds every year, with the rate among children even higher.

Modern biotechnology made its beginning with the development of molecular cloning and recombinant DNA technologies in the early 1970s, following the discovery of the double-stranded DNA structure and deciphering of the genetic code. A very powerful research tool for genetic manipulation became available, making possible what could not have been dreamt of before.

Thank You to Our Sponsor